Arcosa provides infrastructure-related products for construction, engineered structures, and transportation markets. Its results give insight into U.S. infrastructure spending, electricity-grid investment, and construction trends. This quarter comes as the company integrates the Stavola acquisition and refines its focus on construction materials and engineered structures, including plans to divest the inland barge business. Last year's numbers benefited from the acquisition and strong demand, so this period sets up a tougher comparison. I am watching whether organic pricing and backlog strength can hold up against that higher baseline and any shifts in wind-energy policy.
Analysts expect Arcosa to report EPS of roughly $1.55 on revenue near $727.98 million for Q3 2026. That compares with EPS of $1.56 and revenue of $797.80 million a year earlier, pointing to an expected EPS decline of about 0.6% and a revenue decline of roughly 8.8%. The top-line pressure partly stems from the steel components divestiture, the planned barge separation, and the tough year-ago comparison from Stavola. Beyond the headlines, I am tracking adjusted EBITDA, margin performance, and order activity in utility structures and wind towers. Arcosa has beaten consensus EPS in six of the last eight quarters, though the most recent report was a narrow miss. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Sentiment ahead of the report feels measured. Shares have been relatively stable since the August update, and analysts have trimmed estimates modestly, with the full-year consensus EPS forecast down about 2.1% over the past three months. The stock trades at a price-to-earnings ratio near the industry median, suggesting limited aggressive upside is priced in. Key risks include softer organic volumes in construction products, weather issues, and policy uncertainty around wind energy as federal tax credits phase out after 2027. A stronger-than-expected signal on pricing or backlog would stand out as the clearest positive.
Several themes will shape interpretation of the results. Demand in utility and related structures remains a core growth area, with robust order activity supporting grid hardening and a record utility structures backlog offering visibility into 2026 and beyond. Wind tower trends also deserve attention, as the One Big Beautiful Bill Act changes renewable incentives by ending certain manufacturing tax credits for towers sold after 2027; management has noted this could pull some demand forward into 2026, though longer-term visibility is less certain. Construction materials performance will be watched for organic volumes, pricing, and margins as the Stavola integration advances. Finally, updates on the inland barge divestiture, including timing and capital allocation, will matter. Cost absorption, pricing, and backlog trends stay central in the quarters ahead.
From what I see, tools like Tickeron’s AI Screener help me quickly filter infrastructure and construction names against peers on technical patterns, fundamentals, and AI signals. I have used it to refine watchlists and surface comparable opportunities without spending hours on manual screens. It fits naturally into reviewing names like Arcosa when preparing for earnings.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where ACA advanced for three days, in 190 of 312 cases, the price rose further within the following month. The odds of a continued upward trend are 61%.
The Aroon Indicator entered an Uptrend today. In 103 of 229 cases where ACA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 45%.
The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 22 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 22 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Moving Average Convergence Divergence Histogram (MACD) for ACA turned negative on November 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In 32 of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at 68%.
ACA broke above its upper Bollinger Band on October 21, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Profit vs. Risk Rating rating for this company is 11 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 79, placing this stock better than average.
The Tickeron Price Growth Rating for this company is 40 (best 1 - 100 worst), indicating steady price growth. ACA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 50 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 69 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.455) is normal, around the industry mean (15.143). P/E Ratio (14.915) is within average values for comparable stocks, (167.534). Projected Growth (PEG Ratio) (1.863) is also within normal values, averaging (3.522). Dividend Yield (0.001) settles around the average of (0.215) among similar stocks. P/S Ratio (2.444) is also within normal values, averaging (2.886).
The Tickeron PE Growth Rating for this company is 92 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a manufacturer of infrastructure related products
Industry EngineeringConstruction